
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Neurol.
Sec. Headache and Neurogenic Pain
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1577914
This article is a correction to:
Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In the published article, there was an error. [Two reviewer comments inadvertently appeared in the final published article].A correction has been made to [Result section], [Secondary outcomes], This sentence previously stated:Regarding change in monthly headache days, I do not see the relevance to do a sensitivity analysis. Also after excluding Ailani et al., the mean value with 95% CI does not appear so different than the previous one.A correction has been made to [Result section], [meta regression], This sentence previously stated:The meta-regression is not anticipated in the statistical analysis plan. What is the purpose of such analysis?The corrected sentence appears below:“These comments have been removed from the final version of article”The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: atogepant, CGRP, Migraine, Headache, Meta-analysis
Received: 16 Feb 2025; Accepted: 25 Feb 2025.
Copyright: © 2025 Asghar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Muhammad Sohaib Asghar, AdventHealth, Orlando, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.